HOME  > Introduction

Company History

Company History

- 2016

2016 이미지

2008. 06 GM101 phase I clinical trial in Korea

2014. 11 GeneMedicine Co., Ltd., established

2016. 06 Grant Award from KDDF for GM103 development

2016. 07 Licensing Out to USA NASDAQ listed company F

2016. 09 Licensing Out to USA Bio-tech company M

2016. 11 Grant Award from KBIO Health for GM102 development

Establishment

2017 - 2019

2019 이미지

2017. 01 Accredited as bioventure (Kibo)

2018. 04 Accredited as med.-sized business (Ministry of SMEs and Startups)

2018. 12 Received TIPS Grant

2019. 03 Corporate R&D Research Center Accreditation (KOITA)

2019. 05 Series A investment ($15 million)

2019. 06 Relocation of office and research space

2019. 07 Grant Award from KDDF for GM103 development

2019. 11 CDMO Contract (WuXi App Tech)

Business in growth period

2020 -

2020 이미지

2020. 05 Expansion of office and laboratory

2020. 07 Korea's Excellent Patent Award (Hankook Ilbo)

2020. 09 Awardee for Bioinnovative Company

2020. 11 Awardee for Innovation Company (Moneytoday)

2020. 12 Commendation from the Minister of Health and Welfare

2021. 06 Selected as Technology Innovation –Oriented Small and Medium Enterprise(Inno-Biz)

2021. 07 Series B Investment ($ 31 million)

Business in diversification period
TOP